Farid N R, Brioñes-Urbina R, Nazrul-Islam M
J Cell Biochem. 1982;19(4):305-13. doi: 10.1002/jcb.240190402.
We raised an antihuman thyrotropin anti-idiotypic antibody and showed that it was active at the thyrotropin receptor. Thus this antibody inhibited 125I b-TSH binding to thyroid plasma membranes, stimulated adenylate cyclase activity through a guanyl nucleotide-dependent mechanism, increased radioiodide entry rate into isolated porcine thyroid follicular cells, and induced such cultured cells to organize into follicles. All these parameters are typical of thyrotropin action. This work raises the possibility that thyroid stimulating antibodies that cause the hyperthyroidism of Graves disease may be, at least in some patients, anti-thyrotropin anti-idiotypic antibodies. It also offers a novel method whereby antireceptor antibodies used in the isolation and characterization of the receptor may be raised from ligands.
我们制备了一种抗人促甲状腺素抗独特型抗体,并证明它在促甲状腺素受体上具有活性。因此,该抗体抑制了¹²⁵I β-促甲状腺素与甲状腺质膜的结合,通过一种依赖鸟苷酸的机制刺激腺苷酸环化酶活性,提高了放射性碘进入分离的猪甲状腺滤泡细胞的速率,并诱导这些培养细胞组织形成滤泡。所有这些参数都是促甲状腺素作用的典型特征。这项研究提出了一种可能性,即导致格雷夫斯病甲亢的促甲状腺素刺激抗体,至少在某些患者中,可能是抗促甲状腺素抗独特型抗体。它还提供了一种新方法,通过该方法可以从配体中产生用于受体分离和表征的抗受体抗体。